These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9924364)

  • 21. [Digestive cytomegalovirus disease in AIDS patients].
    Barberá JR; Capdevila JA; García-Quintana AM; Calicó I; Allende H; Ruiz I; Ocaña I; Pahissa A
    Enferm Infecc Microbiol Clin; 1996; 14(7):411-5. PubMed ID: 8991434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome].
    Nagata Y; Fujino Y; Ono A; Mochizuki M; Mouri H; Oka S; Kimura S; Shimada K
    Nippon Ganka Gakkai Zasshi; 1994 Jul; 98(7):710-5. PubMed ID: 8067306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic evaluation of systemic treatments for cytomegalovirus retinitis in patients with AIDS.
    Lee TA; Sullivan SD; Veenstra DL; Ramsey SD; Steger PJ; Malinverni R; Pleil AM; Williamson T
    Pharmacoeconomics; 2001; 19(5 Pt 2):535-50. PubMed ID: 11465299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FDA approves oral ganciclovir as first drug to prevent CMV disease. Food and Drug Administration.
    Baker R
    BETA; 1995 Dec; ():8. PubMed ID: 11363015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features and outcomes of cytomegalovirus retinitis after transplantation.
    Eid AJ; Bakri SJ; Kijpittayarit S; Razonable RR
    Transpl Infect Dis; 2008 Feb; 10(1):13-8. PubMed ID: 17511815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytomegalovirus infection in patients with HIV infection.
    Cheung TW; Teich SA
    Mt Sinai J Med; 1999 Mar; 66(2):113-24. PubMed ID: 10100416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of cytomegalovirus retinitis after combination antiretroviral therapy.
    Ruhswurm I; Ries E; Krepler K; Derbolav A; Rieger A; Armbruster C; Wedrich A
    Acta Ophthalmol Scand; 1999 Aug; 77(4):471-3. PubMed ID: 10463426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Studies of Ocular Complications of AIDS Research Group.
    Holbrook JT; Davis MD; Hubbard LD; Martin BK; Holland GN; Jabs DA; Gilpin AK; Meinert C; Reshef DS
    Arch Ophthalmol; 2000 Sep; 118(9):1196-204. PubMed ID: 10980764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinal detachment in cytomegalovirus retinitis: intravenous versus intravitreal therapy.
    Young S; McCluskey P; Minassian DC; Joblin P; Jones C; Coroneo MT; Lightman S
    Clin Exp Ophthalmol; 2003 Apr; 31(2):96-102. PubMed ID: 12648040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytomegalovirus retinitis in AIDS patients: a comparative study of intravenous and oral ganciclovir as maintenance therapy.
    Danner SA; Matheron S
    AIDS; 1996 Dec; 10 Suppl 4():S7-11. PubMed ID: 9110064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cidofovir: a review of its use in cytomegalovirus retinitis in patients with AIDS.
    Plosker GL; Noble S
    Drugs; 1999 Aug; 58(2):325-45. PubMed ID: 10473024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protease inhibitors linked to drop in CMV retinitis.
    AIDS Alert; 1997 Aug; 12(8):92-4. PubMed ID: 11364475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ganciclovir-resistant cytomegalovirus infection: 2 cases with different clinical impact].
    Reusser P; Hostettler B; Attehbofer R
    Schweiz Med Wochenschr; 1996 Oct; 126(42):1779-84. PubMed ID: 8966510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative cytomegalovirus DNA level in the blood and its relationship to cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
    Tufail A; Moe AA; Miller MJ; Wagar EA; Bruckner DA; Holland GN
    Ophthalmology; 1999 Jan; 106(1):133-41. PubMed ID: 9917794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update (1995) on clinical trials of antiviral therapy and prophylaxis for AIDS-related cytomegalovirus disease.
    Jacobson MA
    Scand J Infect Dis Suppl; 1995; 99():96-9. PubMed ID: 8668951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Foscarnet and ganciclovir in the treatment of cytomegalovirus retinitis.
    Polis MA
    J Acquir Immune Defic Syndr (1988); 1992; 5 Suppl 1():S3-10. PubMed ID: 1318365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corneal infiltration and CMV retinitis in a patient with AIDS.
    Inoue T; Hayashi K; Omoto T; Kosaki R; Higaki S; Shimomura Y
    Cornea; 1998 Jul; 17(4):441-2. PubMed ID: 9676918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of cytomegalovirus disease.
    Danner SA
    AIDS; 1995 Dec; 9 Suppl 2():S3-S8. PubMed ID: 8775800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between foscarnet exposure, baseline cytomegalovirus (CMV) blood culture and the time to progression of CMV retinitis in HIV-positive patients.
    Drusano GL; Aweeka F; Gambertoglio J; Jacobson M; Polis M; Lane HC; Eaton C; Martin-Munley S
    AIDS; 1996 Sep; 10(10):1113-9. PubMed ID: 8874628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytomegalovirus optic neuritis: characteristics, therapy and survival.
    Mansor AM; Li HK
    Ophthalmologica; 1995; 209(5):260-6. PubMed ID: 8570149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.